SIETES :: 92577 citas

Resultados de la búsqueda por PAROXETINA REFINAR BÚSQUEDA

1.

Nguyen TTH, Roussin A, Rousseau A, Montastruc J-L, Montastruc F. Role of serotonin transporter in antidepressant-induced diabetes mellitus: A pharmacoepidemiological–pharmacodynamic study in VigiBase®. Drug Saf 2018;41:noviembre. [Ref.ID 102840]

2.

Gafoor R, Booth HP, Gulliford MC. Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ 2018;361:23 de mayo. [Ref.ID 102648]

3.

Anónimo. Antidépresseurs IRS in utero: allongements de l'intervalle QT chez les nouveau-nés. Prescrire 2018;38:189-90. [Ref.ID 102589]

4.

McCormack J, Korownyk C. Effectiveness of antidepressants. BMJ 2018;360:k1073. [Ref.ID 102478]

5.

Cipriani A, Furukwa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. . Lancet 2018;391:7 de abril. [Ref.ID 102476]

6.

Park H-Y, Park J-W, Sohn HS, Kwon JW. Association of parkinsonism or Parkinson disease with polypharmacy in the year preceding diagnosis: a nested case–control study in South Korea . Drug Saf 2017;40:1109-18. [Ref.ID 102104]

7.

Castelpietra G, Gobbato M, Valent F, De Vido C, Balestrieri M, Isacsson G. Antidepressant use in suicides: a case-control study from the Friuli Venezia Giulia Region, Italy, 2005–2014. Eur J Clin Pharmacol 2017;73:883-90. [Ref.ID 101995]

8.

Silverman E. US drug regulators should consider adding adults to SSRI suicide warning, says campaigner. BMJ 2017;357:j2050. [Ref.ID 101550]

9.

Das A, Maiti A, Sinha S. Antidepressant prescription in the geriatric population: a teachable moment. JAMA Intern Med 2016;176:1608-9. [Ref.ID 100959]

10.

Anonimo. Study 329: Why is it so important?. Therapeutics Initiative 1016:1-2. [Ref.ID 100955]

11.

Anónimo. Drugs for menopausal symptoms. Med Lett Drugs Ther 2016;58:142-5. [Ref.ID 100946]

12.

Anónimo. Drugs for depression. Med Lett Drugs Ther 2016;58:85-90. [Ref.ID 100883]

13.

Juurlink D. Revisiting the drug interaction between tamoxifen and SSRI antidepressants. BMJ 2016;354:8 de octubre. [Ref.ID 100796]

14.

Donneyong MM, Bykov K, Bosco-Levy P, Dong Y-H, Levin R, Gagne JJ. Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study. BMJ 2016;354:i5014. [Ref.ID 100795]

15.

Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet 2016;388:881-90. [Ref.ID 100612]

16.

Jureidini J. Antidepressants fail, but no cause for therapeutic gloom. Lancet 2016;388:844-5. [Ref.ID 100611]

17.

Anónimo. Citalopram, escitalopram et allongements de l'intervalle QT. Prescrire 2016;36:348-51. [Ref.ID 100539]

18.

Bérard A, Iessa N, Chaabane S, Muanda FT, Boukhris T, Zhao JP. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis. Br J Clin Pharmacol 2016;81:589-604. [Ref.ID 100178]

19.

Dyer C. GSK is fined £38m for delaying generic paroxetine. BMJ 2016;352:i917. [Ref.ID 100059]

20.

Gotzsche PC. Antidepressants are addictive and increase the risk of relapse. BMJ 2016;352:i574. [Ref.ID 100055]